foropafant has been researched along with Phlegmasia Alba Dolens in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dikshit, M; Kumari, R; Seth, P; Srimal, RC | 1 |
| Bernat, A; Herbert, JM | 1 |
| Bernat, A; Corseaux, D; Herbert, JM; Lale, A | 1 |
3 other study(ies) available for foropafant and Phlegmasia Alba Dolens
| Article | Year |
|---|---|
Effect of platelet activating factor antagonists in different models of thrombosis.
Topics: Animals; Arterial Occlusive Diseases; Azepines; Cats; Diterpenes; Ginkgolides; Lactones; Male; Mice; Mice, Inbred Strains; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Thiazoles; Thrombophlebitis; Triazoles | 1994 |
Effect of various drugs on adriamycin-enhanced venous thrombosis in the rat: importance of PAF.
Topics: Animals; Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Doxorubicin; Leukocyte Count; Male; Platelet Activating Factor; Platelet Count; Rats; Rats, Sprague-Dawley; Thiazoles; Thrombophlebitis; Ticlopidine | 1994 |
Hypoxia primes endotoxin-induced tissue factor expression in human monocytes and endothelial cells by a PAF-dependent mechanism.
Topics: Animals; Cells, Cultured; Endotoxins; Humans; Hypoxia; Interleukin-1; Lipopolysaccharides; Monocytes; Platelet Activating Factor; Rabbits; Thiazoles; Thrombophlebitis; Thromboplastin; Umbilical Cord | 1996 |